Signaling pathway of histone deacetylase inhibitor (HDI) ~Development of Adverse Outcome Pathway (AOP) in OECD~

Shihori Tanabe; Takashi Yamada; Akihiko Hirose

[2P-0005] Signaling pathway of histone deacetylase inhibitor (HDI) ~Development of Adverse Outcome Pathway (AOP) in OECD~

〇Shihori Tanabe¹, Takashi Yamada¹, Akihiko Hirose¹ (1.Div of Risk Assess, Natl Inst of Health Sci)

signaling pathway, Adverse Outcome Pathway, OECD, histone deacetylase inhibitor

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0005] Signaling pathway of histone deacetylase inhibitor (HDI) ~Development of Adverse Outcome Pathway (AOP) in OECD~

Password